Insider Trading & Ownership of DAVID M. MOTT

Location: Baltimore, MD
Summary: The estimated net worth of DAVID M. MOTT is at least $15.9M dollars as of 24 Jun 2025. DAVID M. MOTT is the Director of ARDELYX, INC. and owns shares of ARDELYX, INC. (ARDX) stock worth about $11.8M. DAVID M. MOTT is the Director of IMARA Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $3.47M. DAVID M. MOTT is the Director of NOVAVAX INC and owns shares of NOVAVAX INC (NVAX) stock worth about $704K.
Signature: /s/Mark J. Casey, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when DAVID M. MOTT files a new Insider Trading report.

Ownership of DAVID M. MOTT

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ARDX	ARDELYX, INC.	Director	$11.8M	+$4.78M	+68.6%	18 Jun 2025
ELVN, IMRA	Enliven Therapeutics, Inc.	Director	$3.47M			02 Jun 2022
NVAX	NOVAVAX INC	Director	$704K			20 Jun 2025
ADAP	Adaptimmune Therapeutics PLC	Director				01 Jul 2024
EPZM	Epizyme, Inc.	Director				12 Aug 2022
MRSN	Mersana Therapeutics, Inc.	Director				12 Jun 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.